Investment Summary |
|
|---|---|
| Date | 2021-01-06 |
| Target | Hyundai Glovis |
| Sector | Transportation |
| Investor(s) | The Carlyle Group |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 435.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.
| DEAL STATS | # |
|---|---|
| Overall | 691 of 749 |
| Sector: Transportation M&A | 18 of 18 |
| Type: Stake Purchase M&A Deals | 70 of 73 |
| Country: South Korea M&A | 16 of 17 |
| Year: 2021 M&A | 3 of 28 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-06 |
Amp Solar Group
Port Credit, Ontario, Canada Amp Solar Group is a global renewable energy infrastructure manager, developer, and owner. Amp Energy has successfully developed over 1.8 gigawatts of distributed and utility-scale renewable generation projects, hybrid generation plus storage projects, and stand-alone battery storage projects around the world. Amp Solar Group was founded in 2009 and is based in Port Credit, Ontario. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-08 |
Abbisko Therapeutics
Shanghai, China Abbisko Therapeutics is an oncology focused biopharmaceutical company dedicated to the discovery and development of innovative medicines for unmet medical needs in China and around the world. Abbisko Therapeutics was founded in 2016 and is based in Shanghai, China. |
Buy | - |
